Eli Lilly and Company (LLY · NYSE)
LLY · MARKET VIEW
Market view · as of Jun 1, 2026
Revenue (TTM)
$72.25B
+55.5% YoY
Gross margin
82.8%
EPS (latest q)
$8.55
vs $6.79 est · beat
52-wk position
91.1%
-4.0% vs 52w high · +12.5% 1mo
Price (last ~year)
Eli Lilly and Company (LLY) maintains a significant growth trajectory with year-over-year revenue up 55.5% and earnings up 169.9%, supported by $72.25 billion in TTM revenue. The company, currently valued at $985.37 billion, has posted four consecutive earnings beats, most recently reporting $19.80 billion in revenue and $7.40 billion in net income for the quarter ending March 31, 2026. With gross margins of 82.8% and operating margins of 49.4%, the stock is trading at $1081.96, reflecting a 12.5% gain over the past month.
Valuation
- Market cap
- $985.37B
- P/E
- 39.21
- PEG
- 1.481
- P/B
- 31.58
- P/S
- 13.64
- EV/EBITDA
- 28.26
- Beta
- 0.481
- Analyst target
- $1215.1
Quality & returns
- Gross margin
- 82.8%
- Operating margin
- 49.4%
- Profit margin
- 35.0%
- ROE
- 107.5%
- ROA
- 20.7%
Price movement
- Last
- $1081.96
- 1-month
- +12.5%
- 3-month
- +10.2%
- RSI (14)
- 72
- vs SMA200
- +15.5%
- 52-wk position
- 91.1% -4.0% vs high
Quarterly trajectory
Revenue by quarter (oldest → newest)
| Quarter | Revenue | Op income | Net income | EBITDA |
|---|---|---|---|---|
| 2026-03-31 | $19.80B | $8.85B | $7.40B | $9.36B |
| 2025-12-31 | $19.29B | $8.78B | $6.64B | $8.39B |
| 2025-09-30 | $17.60B | $8.39B | $5.58B | $7.88B |
| 2025-06-30 | $15.56B | $7.13B | $5.66B | $7.50B |
Recent news
- Bullish Eli Lilly and Company (LLY): One of the Top Stocks to Buy Right Now According to AI · 2026-06-01
- Bullish Eli Lilly and Company (LLY): One of the Top Stocks to Buy Right Now According to AI · 2026-06-01
- Somewhat-Bearish Merck & Co Inc Stock (MRK) Moved Down by 3.19% on Jun 1: A Full Analysis · 2026-06-01
- Somewhat-Bullish Fractyl Health Appoints Mike Zumdahl as Senior Vice President, Market Access and Commercial Strategy · 2026-06-01
- Somewhat-Bullish MUFG Securities EMEA plc Purchases 95,736 Shares of CVS Health Corporation $CVS · 2026-06-01
- Bullish Earnings call transcript: Veru Inc Q2 2026 shows improved financials · 2026-06-01
Sources this view read
- fundamentals Company overview & valuation (Alpha Vantage OVERVIEW)
- filing Quarterly financial statements (Alpha Vantage INCOME/BALANCE/CASH)
- earnings Reported earnings history (Alpha Vantage EARNINGS)
- prices Adjusted daily prices (Alpha Vantage TIME_SERIES_DAILY_ADJUSTED)